Global Clinical Nutrition Market Is Estimated To Reach A Market Value Of Us$ 59.8 Billion By 2026, Growing At A Cagr Of 4.4% During 2020-2026 Period
Global Clinical Nutrition Market is estimated to reach a market value of US$ 59.8 billion by 2026, growing at a CAGR of 4.4% during 2020-2026 period
The Clinical Nutrition market is projected to gain market revenue of US$ 59.84 billion by 2026, growing at a CAGR of 4.4% during the forecast period 2020-2026 from US$ 43.48 billion in 2019. The clinical nutrition market is driven by numerous factors such as a rise in the aging population, a rise in the incidence of lifestyle-related disorders, improving health standards and increasing health expenditure and a rise in the count of children suffering from malnutrition among others. In countries like Germany and Japan, fertility rates are declining rapidly. In 2019, Japan’s demographic crisis got worse, as the fast-greying nation experienced its biggest natural population decline and recorded-low birth rate, as per government statistics. The estimated number of babies born in the country in 2019 fell to 864,000. It is lowest since records began in 1899, according to a report published by the Ministry of Health, Labour and Welfare. Moreover, European nations are also experiencing a huge shift in the demographics. Due to this prevalence of age-related diseases such as gastrointestinal diseases are also increasing. Obesity is another condition that is acting as a major burden. It is one of the leading risk factors for premature death. In 2017, it was linked to 4.7 million deaths around the globe. 8% of global deaths were attributed to obesity in 2017. Clinical nutrition is prescribed for patients suffering from such conditions. Oral nutritional supplements may have a role in the management of weight loss in patients with cancer. However, the lack of awareness regarding clinical nutrition and stringent government regulations will hamper market growth.
For Regional/Country analysis of the overall sales of Clinical Nutrition products browse through https://univdatos.com/report/clinical-nutrition-market-current-scenario-and-forecast-2020-2026
Based on product type, the market is fragmented into infant nutrition (milk-based, soy-based and specialized), enteral nutrition (standard fiber-containing, elemental and specialized) and parenteral nutrition (amino acid, dextrose, fats and additives). The infant Nutrition segment occupied the maximum share in the global clinical nutrition market. Adequate nutrition during infancy is essential for lifelong health and wellbeing. The enteral nutrition segment is expected to witness a CAGR growth of 3.8% during the forecast period 2020-2026. Based on end-user, the market is bifurcated into pediatric, adult and Baby Boomers. The adult population segment dominated the market with 65.58% share however, the baby boomer segment is expected to witness the highest CAGR growth of 5.1% during the forecast period 2020-2026. Clinical nutrition is prescribed to the adults suffering from several disorders such as gastrointestinal diseases, diarrhea and to support cell, organ and skeletal, cardiac and respiratory muscle functions, and wound healing.
For Regional/Country analysis of the overall development in the Clinical Nutrition sector browse through https://univdatos.com/report/clinical-nutrition-market-current-scenario-and-forecast-2020-2026
Based on the Distribution channel, the global clinical nutrition market is segmented into convenience stores, supermarket/hypermarket, drug store and online channel. Sales of clinical nutrition through Drug store generated revenue of US$ 16.67 billion in 2019. However, the online sales channel is expected to witness the highest CAGR growth of 6.1% during the forecast period. For in-depth understanding of the market adoption of Clinical Nutrition, detailed analysis was conducted for major regions/countries including North America (US, Canada and rest of North America), Europe (Germany, the UK, France and rest of Europe), Asia-Pacific (Japan, India, China, Indonesia, Pakistan and Rest of Asia-Pacific), and Rest of the World. In 2019, Asia-Pacific dominated the market and is expected to generate revenue of US$ 26.54 billion by 2026. Further, the rise in the geriatric population in Asia-Pacific is estimated to fuel the Clinical Nutrition market in both the regions in the upcoming years.
Request for Sample of the report browse through https://univdatos.com/report/clinical-nutrition-market-current-scenario-and-forecast-2020-2026
Some of the major players profiled in the global Clinical Nutrition study include B. Braun Melsungen AG, Baxter Healthcare, Perrigo, Fresenius Kabi, Pfizer, Nestle, Ajinomoto, Co. Inc., Abbott, Danone, Glanbia, Plc, Lonza Group Ltd., Nutricia North America, Meiji Holdings Co., Ltd., GlaxoSmithKline and H. J. Heinz Company. These industry players are entering into several partnerships for the expansion of their reach and increasing their hold on the market. Some of the key players are also increasing their businesses by setting up new community centers and elder care homes or increasing their expenditure on R&D.
Global Clinical Nutrition Market Segmentation
Market Insights, by Product
- Infant nutrition
- Enteral nutrition
- Standard Fiber Containing
- Parenteral Nutrition
- Amino Acid
Market Insights, by End-Users
- Baby Boomers
Market Insights, by Distribution Channel
- Convenience Stores
- Drug store
- Online Channel
Market Insights, by Region
- North America Clinical Nutrition market
- Rest of North America
- Europe Clinical Nutrition market
- Rest of Europe
- Asia Pacific Clinical Nutrition market
- Rest of Asia-Pacific
- Rest of the World Clinical Nutrition market
Top Company Profiles
- B. Braun Melsungen AG
- Baxter Healthcare
- Fresenius Kabi
- Ajinomoto, Co. Inc.
- Glanbia, Plc
- Lonza Group Ltd.
- Nutricia North America
- Meiji Holdings Co., Ltd.
- H. J. Heinz Company